| Literature DB >> 34420874 |
Annique Claringbould1, Judith B Zaugg2.
Abstract
Enhancers are genomic sequences that play a key role in regulating tissue-specific gene expression levels. An increasing number of diseases are linked to impaired enhancer function through chromosomal rearrangement, genetic variation within enhancers, or epigenetic modulation. Here, we review how these enhancer disruptions have recently been implicated in congenital disorders, cancers, and common complex diseases and address the implications for diagnosis and treatment. Although further fundamental research into enhancer function, target genes, and context is required, enhancer-targeting drugs and gene editing approaches show great therapeutic promise for a range of diseases.Entities:
Keywords: BET inhibition; chromatin organization; complex disease; enhancer; enhanceropathy; epigenetic drugs; gene regulation; genome-wide association studies; structural variation
Mesh:
Year: 2021 PMID: 34420874 DOI: 10.1016/j.molmed.2021.07.012
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951